Investigating Novel Treatment Options For Bcg-Unresponsive Urothelial Carcinoma

Investigating novel treatment options for BCG-unresponsive urothelial carcinoma

Innovations in treatment options for patients with BCG-unresponsive urothelial carcinoma

Novel treatment options for patients with metastatic, inoperable urothelial carcinomas

BCG Unresponsive Disease: A Roadmap for Drug Development and Novel Therapies

Grand Rounds in Urology

Management of BCG Unresponsive Cystectomy Ineligible Bladder Cancer Patients Pembrolizumab

Grand Rounds in Urology

Emerging salvage therapies for BCG-unresponsive non-muscle invasive bladder cancer

UBC Urology Rounds

Introduction to Adstiladrin | Gene Therapy for BCG Unresponsive NMIBC

Bladder Cancer Advocacy Network

BCG Unresponsive Disease

Grand Rounds in Urology

Treatment Options for BCG-Unresponsive NMIBC: Balancing Efficacy, Logistics, and Patient Preferences

GU Oncology Now

Management of Non-Muscle Invasive Bladder Cancer

Pacific Northwest Urology Specialists, PLLC

New treatment of non-muscle-invasive bladder cancer

European Association of Urology

Scott Tagawa, MD, on the study investigating Nadofaragene firadenovec in BCG unresponsive NMIBC

Clinical Investigations in the Treatment of Urothelial Carcinoma

Non-Muscle-Invasive Bladder Cancer Management Post-BCG Therapy | BackTable Urology Clips

BackTable Urology Podcast

Novel Therapies to Non Muscle Invasive Bladder Cancer

UBC Urology Rounds

BCG Unresponsive Non-Muscle Invasive Bladder Cancer

Grand Rounds in Urology

Emerging Treatments for BCG Unresponsive Non-muscle Invasive Bladder Cancer

Grand Rounds in Urology

Immunotherapy for NMIBC: Emerging and Expanding Indications

Grand Rounds in Urology

Advanced/Metastatic Urothelial Carcinoma: Understanding Novel Immunotherapy Maintenance Strategies

PeerView Oncology

High-risk, BCG-unresponsive NMIBC beyond RC: intravesical and systemic therapies